Synopsis
0
USDMF
0
JDMF
0
NDC API
0
VMF
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
CEP/COS
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Certificate Number : CEP 2023-110 - Rev 00
Status : Valid
Issue Date : 2024-05-24
Type : Chemical
Substance Number : 1535
Certificate Number : R1-CEP 2012-083 - Rev 01
Status : Valid
Issue Date : 2020-01-17
Type : Chemical
Substance Number : 1535
Certificate Number : R1-CEP 2013-121 - Rev 00
Status : Valid
Issue Date : 2020-03-31
Type : Chemical
Substance Number : 1535
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
90
PharmaCompass offers a list of Levodropropizine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Levodropropizine manufacturer or Levodropropizine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Levodropropizine manufacturer or Levodropropizine supplier.
A Levodropropizine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Levodropropizine, including repackagers and relabelers. The FDA regulates Levodropropizine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Levodropropizine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Levodropropizine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A Levodropropizine supplier is an individual or a company that provides Levodropropizine active pharmaceutical ingredient (API) or Levodropropizine finished formulations upon request. The Levodropropizine suppliers may include Levodropropizine API manufacturers, exporters, distributors and traders.
click here to find a list of Levodropropizine suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Levodropropizine Drug Master File in Korea (Levodropropizine KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Levodropropizine. The MFDS reviews the Levodropropizine KDMF as part of the drug registration process and uses the information provided in the Levodropropizine KDMF to evaluate the safety and efficacy of the drug.
After submitting a Levodropropizine KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Levodropropizine API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Levodropropizine suppliers with KDMF on PharmaCompass.
A Levodropropizine CEP of the European Pharmacopoeia monograph is often referred to as a Levodropropizine Certificate of Suitability (COS). The purpose of a Levodropropizine CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Levodropropizine EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Levodropropizine to their clients by showing that a Levodropropizine CEP has been issued for it. The manufacturer submits a Levodropropizine CEP (COS) as part of the market authorization procedure, and it takes on the role of a Levodropropizine CEP holder for the record. Additionally, the data presented in the Levodropropizine CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Levodropropizine DMF.
A Levodropropizine CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Levodropropizine CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Levodropropizine suppliers with CEP (COS) on PharmaCompass.
A Levodropropizine written confirmation (Levodropropizine WC) is an official document issued by a regulatory agency to a Levodropropizine manufacturer, verifying that the manufacturing facility of a Levodropropizine active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Levodropropizine APIs or Levodropropizine finished pharmaceutical products to another nation, regulatory agencies frequently require a Levodropropizine WC (written confirmation) as part of the regulatory process.
click here to find a list of Levodropropizine suppliers with Written Confirmation (WC) on PharmaCompass.
Levodropropizine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Levodropropizine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Levodropropizine GMP manufacturer or Levodropropizine GMP API supplier for your needs.
A Levodropropizine CoA (Certificate of Analysis) is a formal document that attests to Levodropropizine's compliance with Levodropropizine specifications and serves as a tool for batch-level quality control.
Levodropropizine CoA mostly includes findings from lab analyses of a specific batch. For each Levodropropizine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Levodropropizine may be tested according to a variety of international standards, such as European Pharmacopoeia (Levodropropizine EP), Levodropropizine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Levodropropizine USP).
